What is the global market size of Drug Delivery Market?

Drug Delivery Market size was valued at USD 17.04 billion in 2021 and is poised to grow from USD 18.47 billion in 2022 to USD 35.21 billion by 2030, growing at a CAGR of 8.4% in the forecast period (2023-2030).

Drug Delivery Companies

Drug Delivery Market Competitive Landscape

Drug Delivery Market Top Player’s Company Profiles

Johnson & Johnson (US)

Pfizer Inc. (US)

Novartis International AG (Switzerland)

GlaxoSmithKline plc (United Kingdom)

Merck & Co., Inc. (US)

Sanofi (France)

AstraZeneca plc (United Kingdom)

Roche Holding AG (Switzerland)

Eli Lilly and Company (US)

Bayer AG (Germany)

Bristol-Myers Squibb Company (US)

AbbVie Inc. (US)

Amgen Inc. (US)

Novo Nordisk A/S (Denmark)

Gilead Sciences, Inc. (US)

Takeda Pharmaceutical Company Limited (Japan)

Biogen Inc. (US)

Astellas Pharma Inc. (Japan)

Boehringer Ingelheim International GmbH (Germany)

Daiichi Sankyo Company, Limited (Japan)

Drug Delivery Market

FAQs

Drug Delivery Market size was valued at USD 18.44 billion in 2022 and is poised to grow from USD 20.02 billion in 2023 to USD 38.17 billion by 2031, growing at a CAGR of 8.4% in the forecast period (2024-2031).

The global drug delivery market is highly competitive and dynamic, characterised by the presence of numerous players operating across various segments and regions. This market encompasses a wide range of technologies and devices designed to deliver drugs efficiently and effectively to patients. The competitive landscape of the global drug delivery market is shaped by factors such as technological advancements, product innovation, strategic collaborations, and regulatory compliance. 'Johnson & Johnson (US)', 'Pfizer Inc. (US)', 'Novartis International AG (Switzerland)', 'GlaxoSmithKline plc (United Kingdom)', 'Merck & Co., Inc. (US)', 'Sanofi (France)', 'AstraZeneca plc (United Kingdom)', 'Roche Holding AG (Switzerland)', 'Eli Lilly and Company (US)', 'Bayer AG (Germany)', 'Bristol-Myers Squibb Company (US)', 'AbbVie Inc. (US)', 'Amgen Inc. (US)', 'Novo Nordisk A/S (Denmark)', 'Gilead Sciences, Inc. (US)', 'Takeda Pharmaceutical Company Limited (Japan)', 'Biogen Inc. (US)', 'Astellas Pharma Inc. (Japan)', 'Boehringer Ingelheim International GmbH (Germany)', 'Daiichi Sankyo Company, Limited (Japan)'

The global drug delivery market is witnessing an increasing trend towards self-administration of medications and home healthcare. Patients are increasingly seeking convenience and independence in managing their medications. User-friendly and portable drug delivery devices such as autoinjectors, inhalers, and insulin pens have emerged to meet this demand. These devices empower patients to administer medications at home, reducing the need for frequent hospital visits and enhancing overall convenience and patient satisfaction.

Increasing focus on targeted drug delivery systems: Targeted drug delivery involves delivering medications directly to specific sites in the body, allowing for localised treatment and minimising systemic side effects. This trend is driven by the need for more precise and effective drug therapies, especially in complex diseases such as cancer, autoimmune disorders, and chronic conditions. Targeted drug delivery systems utilise various technologies such as nanoparticles, liposomes, micelles, and implantable devices to deliver drugs to specific tissues, organs, or cells. These systems offer advantages such as enhanced drug efficacy, reduced dosage requirements, improved patient compliance, and minimise off-target effects.

North America has historically held a significant share in the pacemaker market, attributed to its well-developed healthcare infrastructure, high healthcare expenditure, and a large patient pool. The region has a strong presence of key market players, advanced technological advancements, and a high adoption rate of pacemaker technologies. Additionally, favourable reimbursement policies and increased awareness about cardiovascular diseases contribute to the dominance of North America in the global pacemaker market.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Drug Delivery Market Competitive Landscape

Drug Delivery Market Report Snapshots

Want to customize this report?

FAQs

Request Free Customization

Feedback From Our Clients

$5,300

Drug Delivery Market Competitive Landscape

Drug Delivery Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Drug Delivery Market?

Who are the key vendors in the Drug Delivery Market?

What is the key driver of Drug Delivery Market?

What is the key market trend for Drug Delivery Market?

Which region accounted for the largest share in Drug Delivery Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300